Selagine
Manufacturing · Illinois, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2315 W Taylor St Ste A, Chicago, Illinoi...Website
www.selagine.comRevenue
<$5 MillionIndustry
About Selagine
Selagine Org Chart
Is Selagine your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Selagine is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Selagine
Funding: Get notified immidiatlly once Selagine has new funding data
Earning: See what the market has to say on Selagine recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Selagine launches new products
Selagine, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Selagine has recently received funding, and reach out quickly before it becomes old news!
Click to see if Selagine had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Selagine as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Selagine is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Selagine is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Selagine.
Selagine Tech Stack
A closer look at the technologies used by Selagine
Selagine News & Media
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Selagine
Selagine, Inc. is a spin-out company from the University of Illinois at Chicago that specializes in developing innovative therapeutics for patients with ocular surface diseases caused by inflammatory, immunological, and infectious factors. The company aims to address the needs of individuals suffering from these conditions. Their focus on novel tre... Read More